Skip to content
10-Q

Quarterly Report

SKINOVATION PHARMACEUTICAL INCORPORATED

0001554795-21-000391

← back to feed
Filed
Nov 10, 2021 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · Nov 10, 2021 708K sh
Current Liabilities Q3 2021 · Sep 30, 2021 $370.63K
Current Liabilities Q3 2021 · Dec 31, 2020 $348.69K
Total Liabilities Q3 2021 · Sep 30, 2021 $370.63K
Total Liabilities Q3 2021 · Dec 31, 2020 $348.69K
Current Assets Q3 2021 · Sep 30, 2021 $552
Current Assets Q3 2021 · Dec 31, 2020 $3.55K
Total Assets Q3 2021 · Sep 30, 2021 $552
Total Assets Q3 2021 · Dec 31, 2020 $3.55K
Operating Cash Flow Q3 2021 · Sep 30, 2020 −$7.53K
Cash And Equivalents Q3 2021 · Sep 30, 2020 $4.75K
Cash And Equivalents Q3 2021 · Dec 31, 2019 $77
Stockholders Equity Q3 2021 · Sep 30, 2020 −$337.95K
Stockholders Equity restated Q3 2021 · Jun 30, 2020 $330.8K
Stockholders Equity Q3 2021 · Mar 31, 2020 −$323.79K
Stockholders Equity Q3 2021 · Dec 31, 2019 −$314.19K
Sga Expense Q3 2021 · Sep 30, 2020 $2.7K
Sga Expense Q3 2021 · Sep 30, 2020 $10.83K
Net Income Q3 2021 · Sep 30, 2020 −$7.15K
Net Income Q3 2021 · Sep 30, 2020 −$23.77K
Net Income Q3 2021 · Jun 30, 2020 −$7.02K
Net Income Q3 2021 · Mar 31, 2020 −$9.6K
Operating Income Q3 2021 · Sep 30, 2020 −$2.7K
Operating Income Q3 2021 · Sep 30, 2020 −$10.83K